Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 383
Selected: 0
NCT IDTitle
NCT00022685Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
NCT04469764Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
NCT02672033Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
NCT00742729Increasing Colorectal Cancer Screening Among Filipino Americans
NCT00070343Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
NCT01536743A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression
NCT06090630MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
NCT05523700Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)
NCT00020995Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
NCT0405021568GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
NCT04280471Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease
NCT02683200MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer
NCT00021281Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
NCT02070406Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
NCT00004880Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
NCT03411070SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer
NCT00107159Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma
NCT06067269Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
NCT01345851Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
NCT0336854768Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
NCT01859689Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer
NCT00004050Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
NCT02263898Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutations
NCT00040989BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
NCT03904251CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
NCT06650163Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
NCT01525264Breast Cancer Screening Intervention
NCT00006341Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
NCT00087035Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
NCT00998010Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
NCT00033527INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer
NCT05558904An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
NCT04457232Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
NCT06113016Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
NCT00093548Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer
NCT04705025Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer
NCT00024076Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
NCT00020878Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
NCT02928510Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
NCT04407546Role of Children in Transmission of COVID-19 to Immunocompromised Patients
NCT00098917Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
NCT00301990Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
NCT02940262Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy
NCT00039273Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
NCT02049593PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT02597894Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy
NCT00079222Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT05256641Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
NCT02756130Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)
NCT00335868PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy